These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 17447009
1. Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells. Bijnsdorp IV, van den Berg J, Kuipers GK, Wedekind LE, Slotman BJ, van Rijn J, Lafleur MV, Sminia P. J Neurooncol; 2007 Oct; 85(1):25-31. PubMed ID: 17447009 [Abstract] [Full Text] [Related]
2. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. Kuipers GK, Slotman BJ, Wedekind LE, Stoter TR, Berg Jv, Sminia P, Lafleur MV. Int J Radiat Biol; 2007 Oct; 83(10):677-85. PubMed ID: 17729162 [Abstract] [Full Text] [Related]
3. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ. Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [Abstract] [Full Text] [Related]
4. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells. Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X. J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019 [Abstract] [Full Text] [Related]
6. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers. Xin B, Yokoyama Y, Shigeto T, Futagami M, Mizunuma H. Cancer; 2007 Aug 15; 110(4):791-800. PubMed ID: 17582802 [Abstract] [Full Text] [Related]
7. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. Raju U, Nakata E, Yang P, Newman RA, Ang KK, Milas L. Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):886-94. PubMed ID: 12377342 [Abstract] [Full Text] [Related]
12. A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice. Hofer M, Pospíšil M, Dušek L, Hoferová Z, Weiterová L. Radiat Res; 2011 Aug 01; 176(2):269-72. PubMed ID: 21663397 [Abstract] [Full Text] [Related]
15. Agonist of the adenosine A3 receptor, IB-MECA, and inhibitor of cyclooxygenase-2, meloxicam, given alone or in a combination early after total body irradiation enhance survival of γ-irradiated mice. Hofer M, Pospíšil M, Dušek L, Hoferová Z, Komůrková D. Radiat Environ Biophys; 2014 Mar 01; 53(1):211-5. PubMed ID: 24263216 [Abstract] [Full Text] [Related]
17. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Fujiwara K, Iwado E, Mills GB, Sawaya R, Kondo S, Kondo Y. Int J Oncol; 2007 Oct 01; 31(4):753-60. PubMed ID: 17786305 [Abstract] [Full Text] [Related]
18. [Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells]. Wang CH, Ouyang Q, Tang CW, Huang MH, Li X. Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul 01; 37(4):547-50. PubMed ID: 16909598 [Abstract] [Full Text] [Related]